Difficulty: Medium
Average Score: 86%
Practice
Which of the following CNS stimulants belongs to nootropics?
Correct answer
D
Rationale
In the context of Pharmacological Lifespan Treatment, understanding the classification of CNS stimulants is crucial for selecting appropriate drugs for different age groups. The correct answer is D) Piracetam because it is a nootropic agent that enhances cognitive function and is often used to improve memory, learning, and focus. Nootropics are a specific class of CNS stimulants known for their cognitive-enhancing effects without causing the typical side effects associated with traditional stimulants.
Option A) Camphor is not a CNS stimulant and is commonly used in topical products for its mild analgesic properties. Option B) Pantocrin is a preparation derived from deer antlers and is used in traditional medicine for various purposes, but it is not a recognized nootropic or CNS stimulant. Option C) Sydnocarb is a psychostimulant drug used to treat ADHD and narcolepsy but is not classified as a nootropic.
Educationally, knowing the classification of CNS stimulants, including understanding the distinctions within the category such as the unique properties of nootropics, is essential for healthcare professionals when making informed decisions about drug therapy across different age groups. By grasping these distinctions, practitioners can optimize treatment outcomes while minimizing adverse effects, particularly when considering medications for individuals with varying cognitive needs throughout the lifespan.
Option A) Camphor is not a CNS stimulant and is commonly used in topical products for its mild analgesic properties. Option B) Pantocrin is a preparation derived from deer antlers and is used in traditional medicine for various purposes, but it is not a recognized nootropic or CNS stimulant. Option C) Sydnocarb is a psychostimulant drug used to treat ADHD and narcolepsy but is not classified as a nootropic.
Educationally, knowing the classification of CNS stimulants, including understanding the distinctions within the category such as the unique properties of nootropics, is essential for healthcare professionals when making informed decisions about drug therapy across different age groups. By grasping these distinctions, practitioners can optimize treatment outcomes while minimizing adverse effects, particularly when considering medications for individuals with varying cognitive needs throughout the lifespan.